Basmayor, Clarence S.

HRN: 27-61-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
CEFTRIAXONE 1G (VIAL)
08/08/2025
08/15/2025
IV
1g
Q12
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: